Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1261 (MIR1261) is a short (20–24 nucleotide) non-coding RNA molecule classified as a microRNA (miRNA), which participates in post-transcriptional gene regulatory processes in multicellular organisms by modulating the stability and translation of messenger RNAs through imperfect base pairing[1]. MIR1261, like other miRNAs, is transcribed as part of capped and polyadenylated primary transcripts, processed by Drosha and Dicer ribonucleases to yield a mature miRNA that joins the RNA-induced silencing complex (RISC) to guide gene silencing. While miRNAs generally regulate various biological processes and can have significant disease roles, current evidence does not highlight specific, well-supported disease associations or therapeutic targeting for MIR1261 at this time[1].
Not applicable (No drugs targeting this microRNA are reported)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 1261 (MIR1261).